- Article
Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer’s Disease
- María Sánchez-Campillo,
- María José Ruiz-Pastor,
- Antonio Gázquez,
- Juan Marín-Muñoz,
- Fuensanta Noguera-Perea,
- Antonio J. Ruiz-Alcaraz,
- Salvadora Manzanares-Sánchez,
- Carmen Antúnez and
- Elvira Larqué
The protein Major Facilitator Superfamily Domain containing 2A (MFSD2a) was recently described as the primary carrier for docosahexaenoic acid (DHA) into the brain. Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characteri...